Valuation Vertex Pharmaceuticals Incorporated Sao Paulo

Stocks

Market Closed - Sao Paulo 19:56:46 08/09/2026 BST			5-day change	1st Jan Change
84.20 ^BRL	-4.03%		-4.45%	+7.62%

09-02	Evercore ISI Adjusts Vertex Pharmaceuticals Price Target to $600 From $535, Maintains Outperform Rating	MT
09-01	Vertex Pharmaceuticals Incorporated Announces Chief Financial Officer Changes, Effective January 1, 2027	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	55,834	74,127	104,849	103,707	115,026	134,055	-	-
Change	-	32.76%	41.44%	-1.09%	10.91%	16.54%	-	-
Enterprise Value (EV) ¹	48,309	63,349	93,630	97,591	108,418	128,754	125,803	126,960
Change	-	31.13%	47.8%	4.23%	11.09%	18.76%	-2.29%	0.92%
P/E	24.4x	22.5x	29.3x	-194x	29.6x	54.4x	28.7x	24.2x
PBR	5.53x	5.33x	5.96x	6.4x	6.17x	7.69x	6.4x	5.39x
PEG	-	0.5x	3.51x	2x	-0x	-1.5x	0.3x	1.3x
Capitalization / Revenue	7.37x	8.3x	10.6x	9.41x	9.58x	10.1x	9.25x	8.17x
EV / Revenue	6.38x	7.09x	9.49x	8.86x	9.03x	9.72x	8.68x	7.74x
EV / EBITDA	10.8x	12.8x	20.6x	108x	19.8x	42.6x	20x	18.5x
EV / EBIT	11.1x	13.2x	21.4x	140x	20.6x	27.2x	20.9x	18.2x
EV / FCF	20.1x	16.1x	28.1x	-123x	33.9x	736x	27.7x	25.1x
FCF Yield	4.99%	6.2%	3.56%	-0.81%	2.95%	0.14%	3.6%	3.99%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	9.01	12.82	13.89	-2.08	15.32	9.729	18.45	21.85
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	7,574	8,931	9,869	11,020	12,001	13,251	14,497	16,408
EBITDA ¹	4,470	4,941	4,556	902.8	5,473	3,023	6,292	6,851
EBIT ¹	4,344	4,793	4,375	695.6	5,263	4,737	6,030	6,969
Net income ¹	2,342	3,322	3,620	-535.6	3,953	2,535	4,831	5,688
Net Debt ¹	-7,525	-10,778	-11,218	-6,116	-6,608	-5,301	-8,252	-7,096
Reference price ²	219.60	288.78	406.89	402.70	453.36	528.90	528.90	528.90
Nbr of stocks (in thousands)	254,252	256,691	257,683	257,529	253,719	253,461	-	-
Announcement Date	26/01/22	07/02/23	05/02/24	10/02/25	12/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	31.99x	11.64x	23.74x	0.62%	1,002B
JOHNSON & JOHNSON	29.94x	-	-	2%	649B
ABBVIE INC.	31.86x	7.4x	15.38x	2.76%	440B
ROCHE HOLDING AG	19.06x	4.64x	11.51x	2.86%	346B
NOVARTIS AG	19.62x	5.13x	12.72x	3.16%	263B
ASTRAZENECA PLC	20.69x	4.25x	12.14x	2.08%	250B
AMGEN INC.	24.87x	6.52x	11.97x	2.57%	213B
NOVO NORDISK A/S	13.02x	4.72x	9.85x	3.87%	201B
GILEAD SCIENCES, INC.	-44.81x	6.47x	25.27x	2.25%	182B
Average	16.25x	6.35x	15.32x	2.46%	393.74B
Weighted average by Cap.	23.18x	7.75x	17.28x	2.03%